Prognostic factors for patients with culture-positive Candida infection undergoing abdominal surgery

Journal of Microbiology, Immunology and Infection

Volumn 42, Issue 5, 2009, Pages 378-384

  Hsu, Feng Chien ^a   Lin, Po Chang ^b   Chi, Chih Yu ^b   Ho, Mao Wang ^b   Ho, Cheng Mao ^b   Wang, Jen Hsien ^b  

^a TUNGS' TAICHUNG METROHARBOR HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Abdomen; Candida; Prognosis; Risk factors; Surgical procedures, operative

Indexed keywords

ABDOMINAL SURGERY; ABSCESS; ADULT; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; FEMALE; FUNGUS CULTURE; GRAM NEGATIVE SEPSIS; HIGH RISK PATIENT; HUMAN; INFECTION RISK; LAPAROTOMY; MALE; MORTALITY; PERITONEAL FLUID; PROGNOSIS; SURGICAL PATIENT; TAIWAN;

ABDOMINAL ABSCESS; ADULT; AGED; AGED, 80 AND OVER; ASCITIC FLUID; BILE; CANDIDA; CANDIDIASIS; FEMALE; HOSPITALS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; TAIWAN;

EID: 77749308616     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Winston DJ, Pakrasi A, Busuttil RW. Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1999;131:729-37.
2. Laupland KB, Gregson DB, Church DL, Ross T, Elsayed S. Invasive Candida species infections: a 5 year population-based assessment, J Antimicrob Chemother. 2005;56:532-7.
3. Beck-Sagué C, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis. 1993;167:1247-51.
4. Krzeminśka-Jaśkowiak E, Michalska W, Cybulski Z, Chylak J. The presence of bacteria and yeast like fungi in specimens from surgical patients. Med Dosw Mikrobiol. 2003;55:189-95. [Article in Polish.]
5. Solomkin JS, Mazuski JE, Baron EJ, Sawyer RG, Nathens AB, DiPiro JT, at al. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis. 2003;37:997-1005.
6. Shorr AF, Chung K, Jackson WL, Waterman FE, Kollef MH. Fluconazole prophylazis in critically ill surgical patents: a meta-analysis. Crit Care Med. 2005;33:1928-35.
7. Pelz RK, Hendrix CW, Swoboda SM, Ener-West M, Merz WG, Hammond J, et al. Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg. 2001;233:542-8.
8. Vardakas KZ, Samonis G, Michalopoulos A, Soteriades ES, Falagas ME. Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials. Crit Care Med. 2006;34:1216-24.
9. Ota Y, Tatsuno K, Okugawa S. Yanagimoto S, Kitazawa T, Fukushima A, et al. Relationship between the initial dose of micafungin and its efficacy in patients with candidemia. J Infect Chemother. 2007;13:208-12.
10. Bone RC, Balk BA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644-55.
11. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al; SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conferenee. Crit Care Med. 2003;31:1250-6.
12. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(Suppl 1):S1-266.
13. Kung HC, Wang JL, Chang SC, Wang JT, Sun HY, Hsueh PR, at al. Community-onset candidemia at a university hospital, 1995-2005. J Microbiol Immunol Infect. 2007;40:355-63.
14. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg. 1994;220:751-8.
15. Eggimann P, Francioli P, Bille J, Schneider R, Wu MM, Chapuis G, et al. Fluconazole prophylaxis prevents intrabdominal candidiasis in high-risk surgical patients. Crit Care Med. 1999;27:1066-72.
16. Campillo B, Richardet JP, Kheo T, Dupeyron C. Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patents: impact of isolate type on prognosis and characteristics of infection. Clin Infect Dis. 2002;35:1-10.
17. Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH. Manual of clinical microbiology. In: Hazen KC, Howell SA, eds. Candida, Cryptococcus, and other yeasts of medical importance. Vol 8. 8th ed. Washington: American Society for Microbiology Press; 2003:1693-711.
18. Gutierrez J, Martin E, Lozano C, Coronilla J, Nogales C. Evaluation of the ATB 32C, automicrobic system and API 20C using clinical yeast isolates. Ann Biol Clin. 1994;52:443-6.
19. Sandven P, Qvist H, Skovlund E, Giercksky KE; NORGAS Group and the Norwegian Yeast Study Group. Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations. Crit Care Med. 2002;30:541-7.
20. Calandra T, Bille J, Schneider R, Mosimann F, Francioli P. Clinical significance of Candida isolated from peritoneum in surgical patients. Lancet 1989;2:1437-40.
21. Lee SC, Thing CP, Chen HY, Li CT, Jwo SC, Hung YB, et al. Candida peritonitis due to peptic ulcer perforation: incidence rate, risk factors, prognosis and susceptibility to fluconazole and amphotericin B. Diagn Microbiol Infect Dis. 2002;44:23-7.
22. Sandven P, Giercksky KE; NORGAS Group, and the Norwegian Yeast Study Group. Yeast colonization in surgical patients with intra-abdominal perforations. Eur J Clin Microbiol Infect Dis. 2001;20:475-81.
23. Kusne S, Tobin D, Pasculle AW, Van Thiel DH, Ho M, Starzl TE. Candida carriage in the alimentary tract of liver transplant candidates. Transplantation. 1994;57:398-402.
24. Playford EG, Webster AC, Sorrell TC, Craig JC. Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials. J Antimicrob Chemother. 2006;57:628-38.
25. Aikawa N, Sumiyama Y, Kusachi S, Hirasawa H, Oda S, Yamazaki Y. Use of antifungal agents in febrile patients nonresponsive to antibacterial treatment the current status in surgical and critical care patients in Japan. J Infect Chemother. 2002;8:23741.
26. De Waele JJ, Vogelaers D, Blot S, Colardyn F. Fungal infections in patients with severe acute pancreatitis and the use of prophylactic therapy. Clin Infect Dis. 2003;37:208-13.
27. Romani L, Kaufmann SH. Immunity to fungi: editorial overview. Res Immunol. 1998;149:277-81.
28. Dean DA, Burchard KW. Surgical perspective on invasive Candida infections. World J Surg. 1998;22:127-34.